DI
RLAY icon

Disciplined Investments’s Relay Therapeutics RLAY Stock Holding History

Disciplined Investments’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed -$38 – 1236
2023
Q2 		$38 Sell
3
-1
-25% -$12 ﹤0.01% 1671
2023
Q1 		$66 Buy
+4
New +$72 ﹤0.01% 1616
2022
Q4 		– Sell
-4
Closed – – 1683
2022
Q3 		$0 Buy
4
+3
+300% +$66 ﹤0.01% 1548
2022
Q2 		$0 Buy
+1
New +$21 ﹤0.01% 1563

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Disciplined Investments's RLAY Position: Q3 2023 in Review

Disciplined Investments sold out of Relay Therapeutics (RLAY) in Q3 2023, closing a stake of 3 shares — an estimated $38 sold.

Disciplined Investments first reported a position in RLAY in Q2 2022 and held it in 4 quarters. The position peaked at $66 in Q1 2023. 172 funds tracked by Wall St. Rank hold RLAY as of Q3 2023.

  • Disciplined Investments reported no remaining Relay Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 3 Relay Therapeutics shares in Q3 2023, an estimated $38.
  • Disciplined Investments first reported a position in Relay Therapeutics in Q2 2022 and held it in 4 quarters.
  • Disciplined Investments's Relay Therapeutics position peaked at $66 in Q1 2023.
  • 172 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.